STAT News reports: The Food and Drug Administration today approved the oral version of Novo Nordisk’s injectable weight loss drug Wegovy, making it the first

The next transformative phase of weight-loss medication is upon us, with the US Food and Drug Administration (FDA) approving Novo Nordisk’s highly anticipated oral GLP-1

Our platform aggregates and organizes all relevant market news, helping you stay informed, up-to-date, and knowledgeable without spending hours sifting through headlines. Reinvented to keep

The announcement has not been a hit with everyone. While some were excited, many people on the internet have roasted the fast food chain over

CMS published plans Dec. 23 for its voluntary “Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth” — or BALANCE — model. The announcement comes

Dec ‌23 (Reuters) – ​The U.S. ‌Centers ​for ‍Medicare and ​Medicaid ​Services said ⁠on Tuesday it ‌will negotiate drug ​pricing with ‌manufacturers…

The S&P 500 finished up 0.5% at 6,909.79, narrowly topping a record set earlier this month. (EPA Images pic) NEW YORK: The S&P 500 powered

Leptin resistance limits anti-obesity efficacy. We identified a leptin-sensitizing mechanism through tirzepatide (TZP), a glucagon-like peptide-1 receptor (GLP-1R) and glucose-dependent insulinotropic polypeptide receptor (GIPR) dual-agonist.

US health agency to negotiate prices for GLP-1 weight-loss drugs (www.reuters.com) 06:10  

The Commerce Department reported that the U.S. economy grew 4.3 percent in the third quarter, topping expectations. NTD looks at what drove the uptick. A

A pill version of the popular GLP-1 weight-loss drug Wegovy has been greenlit for use in the U.S. Here’s what that means for health care

People who are squeamish about needles will soon have an alternative, as the Food and Drug Administration has approved a pill version of Wegovy that

The first-ever oral GLP-1 medication for weight loss has been approved for use in the U.S. The Wegovy pill, from drugmaker Novo Nordisk, was cleared

Novo Nordisk Newsroom The United States Food and Drug Administration (FDA) has approved a new oral version of the weight loss medication Wegovy, developed by

#Chipotle #Protein #GLP1 For more context and news coverage of the most important stories of our day, click here: https://www.nbcnews.com » Subscribe to NBC News:

Needles are no longer the only way to take groundbreaking GLP-1 drugs.

CNBC’s Annika Kim Constantino reports on the FDA’s approval of the first GLP-1 pill for obesity from Wegovy maker Novo Nordisk.

Novo Nordisk’s latest innovation is expected to be available next month.

For Immediate Release Chicago, IL – December 23, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks

Good news for people who are terrified of needles but interested in taking a GLP-1: Weight-loss pills are on the way. On Monday, the FDA

What are agrifoodtech startups tracking as we head into 2026? To find out, we fired off some emails to companies we’ve covered on AgFunderNews this year.

In the last 5 days ChatGPT read 146994 top news stories. After removing previously covered events, there are 9 articles with a significance score over

People turning to injectable GLP-1 treatments—a class of drugs that mimics that hormone to control diabetes and promote weight loss—now have another way to take

Households that start taking blockbuster GLP-1 appetite suppressants like Ozempic and Wegovy slash food spending within months, according to a study.

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top

Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend

The FDA has just approved the first oral GLP-1 drug for weight management. Clinical data shows it can reduce weight by about 16%, which is

Quick Read Novo Nordisk (NVO) received FDA approval for the first oral Wegovy pill. The once-daily tablet delivered 16.6% average weight loss over 64 weeks.

Beyond weight reduction and long-term maintenance of weight loss, the FDA decision for oral Wegovy covers use of the once-daily pill for reducing the risk

FDA approves Wegovy pill for weight loss, the first daily oral medication of its kind  CBS News F.D.A. Approves Wegovy Weight-Loss Pill  The New York Times Novo

Novo’s Wegovy pill to test demand from consumers with cash  Reuters Novo Nordisk stock surges on hopes Wegovy pill approval will deliver some ‘redemption’ for investors  CNBC

(MedPage Today) — The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent indicated for

The FDA has approved Novo Nordisk’s pill version of Wegovy, making it the first oral GLP-1 receptor agonist therapy cleared for chronic weight management. The

It’s the first GLP-1 pill approved for treating obesity.

Chipotle Mexican Grill, Inc. (NYSE:CMG) is one of the 13 Best Fast Food Stocks to Buy. On December 19, Evercore ISI reiterated its Outperform rating

Published on December 23, 2025 2:17 PM GMT I am fascinated by the beautiful who become deformed. Some become bitter, more bitter than those born

GLP-1 agonists are pivotal in obesity care, promoting weight loss and addressing related health issues, with a focus on personalized, holistic treatment.

Good morning, Pharmalittle readers. This is Allison DeAngelis, filling in for Mr. Pharmalot. Today’s newsletter is brought to you by the dark roast Keurig pods

Novo Nordisk’s Wegovy pill, the first weight-loss drug to win approval from the agency, is expected to launch in the US in early 2026.